All Press Releases for June 25, 2024

Betty Sue Pace, MD, has been Inducted into the Prestigious Marquis Who's Who Biographical Registry

Betty Sue Pace, MD, is a professor of pediatrics at Augusta University.



Her dedication to developing new drugs for sickle cell disease has been instrumental in advancing treatment options, particularly for patients in resource-limited areas such as sub-Saharan Africa.

    AUGUSTA, GA, June 25, 2024 /24-7PressRelease/ -- Betty Pace for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Pace is a professor of pediatrics at Augusta University, where she has served since 2012. With over a decade in her current role, she oversees the research lab, ensuring that goals and metrics are met while facilitating training programs. Her expertise in sickle cell disease has earned her recognition as a leading figure in the field. Her dedication to developing new drugs for sickle cell disease has been instrumental in advancing treatment options, particularly for patients in resource-limited areas such as sub-Saharan Africa.

Prior to her tenure at Augusta University, Dr. Pace was a scientist physician at MCG Lester University in 20 l0. Her work there involved patient care and establishing an independent lab focused on sickle cell research. From 1994 to 2002, she held a faculty position at the University of South Alabama, dedicating 80% of her time to research and clinical care. Earlier in her career, she was also a faculty member at the Children's Hospital of Wisconsin.

Dr. Pace's contributions to the medical field extend beyond her roles in academia. She has been inducted into the Alpha Omega Alpha Honor Medical Society and was named an inaugural person in leadership by the American Society of Hematology. Her numerous professional affiliations include memberships in the American Society of Hematology, the American Society of Pediatric Hematology/Oncology, the American Society of Human Genetics, the National Black Physician Society, the Society for Pediatric Research and the Medical College of Wisconsin Alumni Association.

Dr. Pace's academic background forged the path for her successful career in pediatric hematology and sickle cell disease research, beginning with a Doctor of Medicine from the Medical College of Wisconsin in 1976. She completed her residency at the same institution in 1984 and subsequently pursued a fellowship in Colorado from 1987 to 1990. She attributes her success to her servant-hearted approach to medicine, believing that being a servant is essential for anyone in the medical profession. She also emphasizes the importance of supporting underrepresented investigators dedicated to improving the lives of patients with sickle cell disease and other genetic disorders.

Regarding Dr. Pace's career highlights, an accomplishment that stands out is the significant strides she made in developing new drugs for sickle cell disease, a field that has seen limited progress in the past two decades. With only one FDA-approved drug for sickle cell disease available for over 20 years, the recent development of three new drugs from 2017 to 2019 is a step in the right direction, but there remains an urgent need for more effective treatments. Her work not only impacts sickle cell disease but also extends to other noncancerous blood disorders, making a significant difference in the care of individuals with these conditions.

In addition to her academic and professional accomplishments, Dr. Pace is actively involved in civic organizations. She serves as a board member for the Sickle Cell Disease Association of America Inc., reflecting her commitment to community service and advocacy. Her contributions have been recognized with awards such as Scientist of the Year from the American Medical Women's Association.

Although Dr. Pace plans to retire within the next few years, she is determined to ensure a smooth handover to young, talented individuals who will continue her legacy. Her career is marked by significant achievements in sickle cell disease research and a deep commitment to mentoring future medical professionals, and her work continues to make a profound impact on both patients and colleagues alike.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
USA
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: